Skip to main content
Log in

Echocardiographic parameters to predict inadequate defibrillation safety margin in patients receiving implantable cardioverter defibrillators for primary prevention

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Background

Implantable cardioverter defibrillators (ICDs) have become an important part of the management of patients with congestive heart failure. At the time of ICD implantation, ventricular fibrillation (VF) is induced to assess adequate energy required for defibrillation. There are multiple parameters which influence the defibrillation safety margin (DSM); however, these factors are not well-established when ICDs are implanted for the primary prevention of sudden cardiac death (SCD) in patients with severe systolic dysfunction. We evaluated multiple clinical and echocardiographic parameters as predictors of adequate DSM in patients referred for ICD implantation for the primary prevention of SCD.

Methods

We prospectively enrolled 41 patients for ICD implantation with clinical indications for the primary prevention of SCD. Two blinded independent readers evaluated the prespecified echocardiographic parameters. These included left ventricular (LV) mass, indices of right ventricular and LV systolic and diastolic functions, and LV geometric dimensions. Basic clinical demographics, including age, gender, comorbidities, and etiology of cardiomyopathy, were also evaluated. DSM was established using our standard protocol for defibrillation testing which includes VF with successful first shock terminating VF at a value at least 10 J below the maximum output of the implanted device. High defibrillation thresholds (DFT) were defined as >21 J.

Results

The mean age is 61.8 ± 14.7 years, with men comprising the majority of the patients (73 %). The only clinical variables which predicted the high DFT were age (in years) (54.5 ± 17.5 vs. 65.7 ± 11.3, p = 0.044), QRS duration (in milliseconds) (116.0 ± 29.5 vs. 110.5 ± 21.8, p = 0.03), LV mass (in grams) (241.0 ± 77.9 vs. 181.9 ± 52.3, p = 0.006), and LV mass index (in grams per square meter) (111.1 ± 38.2 vs. 86.4 ± 21.1, p = 0.02). On multivariate logistic regression analysis, LV mass was the only independent predictor of low DFT (≤22 J) in patients with ICD implanted for the primary prevention of SCD.

Conclusion

LV mass may help predict an adequate DSM in patients who are referred for ICD implantation for the primary prevention of SCD. These results may help distinguish the patients who may require high-energy devices prior to the implantation procedure. These results may help distinguish patients requiring high-energy devices, coils, or advanced programming prior to implantation and appropriate referral to electrophysiologists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A., 3rd, Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., Hlatky, M. A., Newby, L. K., Page, R. L., Schoenfeld, M. H., Silka, M. J., Stevenson, L. W., Sweeney, M. O., Smith, S. C., Jr., Jacobs, A. K., Adams, C. D., Anderson, J. L., Buller, C. E., Creager, M. A., Ettinger, S. M., Faxon, D. P., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R. A., Ornato, J. P., Page, R. L., Riegel, B., Tarkington, L. G., & Yancy, C. W. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 51, e1–e62.

    Article  PubMed  Google Scholar 

  2. Mark, D. B., Nelson, C. L., Anstrom, K. J., Al-Khatib, S. M., Tsiatis, A. A., Cowper, P. A., Clapp-Channing, N. E., Davidson-Ray, L., Poole, J. E., Johnson, G., Anderson, J., Lee, K. L., & Bardy, G. H. (2006). Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: Results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation, 114, 135–142.

    Article  PubMed  CAS  Google Scholar 

  3. Curtis, A. B., Ellenbogen, K. A., Hammill, S. C., Hayes, D. L., Reynolds, D. W., Wilber, D. J., & Cain, M. E. (2004). Clinical competency statement: Training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. Heart Rhythm, 3, 371–375.

    Article  Google Scholar 

  4. Gerstenfeld, E. P. (2005). Defibrillation threshold testing: Is one shock enough? Heart Rhythm, 2, 123–124.

    Article  PubMed  Google Scholar 

  5. Birnie, D., Tung, S., Simpson, C., Crystal, E., Exner, D., Ayala Paredes, F. A., Krahn, A., Parkash, R., Khaykin, Y., Philippon, F., Guerra, P., Kimber, S., Cameron, D., & Healey, J. S. (2008). Complications associated with defibrillation threshold testing: The Canadian experience. Heart Rhythm, 5, 387–390.

    Article  PubMed  Google Scholar 

  6. Marchlinski, F. E., Flores, B., Miller, J. M., Gottlieb, C. D., & Hargrove, W. C., 3rd. (1988). Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator. The American Journal of Cardiology, 62, 393–398.

    Article  PubMed  CAS  Google Scholar 

  7. Russo, A. M., Sauer, W., Gerstenfeld, E. P., Hsia, H. H., Lin, D., Cooper, J. M., Dixit, S., Verdino, R. J., Nayak, H. M., Callans, D. J., Patel, V., & Marchlinski, F. E. (2005). Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm, 2, 456–461.

    Article  PubMed  Google Scholar 

  8. Mainigi, S. K., Cooper, J. M., Russo, A. M., Nayak, H. M., Lin, D., Dixit, S., Gerstenfeld, E. P., Hsia, H. H., Callans, D. J., Marchlinski, F. E., & Verdino, R. J. (2006). Elevated defibrillation thresholds in patients undergoing biventricular defibrillator implantation: Incidence and predictors. Heart Rhythm, 3, 1010–1016.

    Article  PubMed  Google Scholar 

  9. Raitt, M. H., Johnson, G., Dolack, G. L., Poole, J. E., Kudenchuk, P. J., & Bardy, G. H. (1995). Clinical predictors of the defibrillation threshold with the unipolar implantable defibrillation system. Journal of the American College of Cardiology, 25, 1576–1583.

    Article  PubMed  CAS  Google Scholar 

  10. Kopp, D. E., Blakeman, B. P., Kall, J. G., Olshansky, B., Kinder, C. A., & Wilber, D. J. (1995). Predictors of defibrillation energy requirements with nonepicardial lead systems. Pacing and Clinical Electrophysiology, 18, 253–260.

    Article  PubMed  CAS  Google Scholar 

  11. Burke, P. T., Ghanbari, H., Alexander, P. B., Shaw, M. K., Daccarett, M., & Machado, C. (2010). A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): Should defibrillation threshold testing be performed post-(MRI). Journal of Interventional Cardiac Electrophysiology, 28, 59–66.

    Article  PubMed  Google Scholar 

  12. Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., Solomon, S. D., Spencer, K. T., Sutton, M. S., & Stewart, W. J. (2005). Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography, 18, 1440–1463.

    Article  PubMed  Google Scholar 

  13. Uyguanco, E. R., Berger, A., Budzikowski, A. S., Gunsburg, M., & Kassotis, J. (2008). Management of high defibrillation threshold. Expert Rev Cadiovasc Ther, 6, 1237–1248.

    Article  Google Scholar 

  14. Chen, P. S., Wolf, P. D., & Ideker, R. E. (1991). Mechanism of cardiac defibrillation: A different point of view. Circulation, 84, 913–919.

    Article  PubMed  CAS  Google Scholar 

  15. Rodriguez, B., Eason, J. C., & Trayanova, N. A. (2006). Differences between left and right ventricular anatomy determine the type of reentrant circuits induced by an external electric shock. A rabbit heart simulation study. Progress in Biophysics and Molecular Biology, 90, 399–413.

    Article  PubMed  Google Scholar 

  16. Chapman, P. D., Sagar, K. B., Wetherbee, J. N., & Troup, P. J. (1987). Relationship of left ventricular mass to defibrillation threshold for the implantable defibrillator: A combined clinical and animal study. American Heart Journal, 114, 274–278.

    Article  PubMed  CAS  Google Scholar 

  17. Hodgson, D. M., Olsovsky, M. R., Shorofsky, S. R., Daly, B., & Gold, M. R. (2002). Clinical predictors of defibrillation thresholds with an active pectoral pulse generator lead system. PACE, 25, 408–413.

    Article  PubMed  Google Scholar 

  18. Horton, R. P., Canby, R. C., Roman, C. A., Hull, M. L., Kaye, S. A., Jessen, M. E., & Page, R. L. (1997). Determinants of nonthoracotomy biphasic defibrillation. PACE, 20, 60–64.

    Article  PubMed  CAS  Google Scholar 

  19. Lubinski, A., Lewicka-Nowak, E., Zienciuk, A., Krolak, T., Kempa, M., Pazdyga, A., & Swiatecka, G. (2005). Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators. Kardiologia Polska, 62, 317–328.

    PubMed  Google Scholar 

  20. Schuger, C., Ellenbogen, K. A., Faddis, M., Knight, B. P., Yong, P., & Sample, R. (2006). Defibrillation energy requirements in an ICD population receiving cardiac resynchronization therapy. Journal of Cardiovascular Electrophysiology, 17, 247–250.

    Article  PubMed  Google Scholar 

  21. Kolb, C., Tzeis, S., & Zrenner, B. (2009). Defibrillation threshold testing: Tradition or necessity? Pacing and Clinical Electrophysiology, 32, 570–572.

    Article  PubMed  Google Scholar 

  22. Strickberger, S. A., & Klein, G. J. (2004). Is defibrillation testing required for defibrillator implantation? Journal of the American College of Cardiology, 44, 88–91.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Funding was provided by the Research Department at St. John Providence Hospital, Southfield, MI, USA.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian Machado.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jain, S.K.A., Ghanbari, H., Hourani, R. et al. Echocardiographic parameters to predict inadequate defibrillation safety margin in patients receiving implantable cardioverter defibrillators for primary prevention. J Interv Card Electrophysiol 37, 79–85 (2013). https://doi.org/10.1007/s10840-012-9764-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-012-9764-4

Keywords

Navigation